Replicate design studies in Phoenix/WinNonlin [Software]

posted by Helmut Homepage – Vienna, Austria, 2010-04-09 19:47 (5913 d 05:30 ago) – Posting: # 5068
Views: 22,671

Dear Simon!

Agree with all your points. The original post dealt with Ae0-t; in bioequivalence only NCA is acceptable to regulators – so I was asking the heretic question about extrapolation. But let sleeping dogs lie.

And you are right, in development of an NCE everybody would model anyway.

❝ […] whether there is any benefit to the WNL user / general PK community of Phoenix implementing the extrapolation Herr Doktor Rotter described in TopFit


Well, the post was D. Labes’, not Hermann’s. ;-)
I don’t consider it of any importance at all.

We have bigger problems – no mixed effects model in BE according to the new European Guideline. That’s really a problem – right now

I don’t see any possibility to evaluate a replicate design study with PHX/WNL!

Or as our Indian friends use to say: Please correct me if I am wrong.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
275 visitors (0 registered, 275 guests [including 128 identified bots]).
Forum time: 01:18 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5